ECZEMA (ATOPIC DERMATITIS)
Eczema is a common condition which affects 2.4 – 7 % of the population. It is described as a chronic,
pruritic, inflammatory skin condition. The skin is dry and hyperkeratotic; lesions include excoriations, papules, eczema (patches
of erythema, exudation, and scaling with small vesicles formed within the epidermis), and lichenification (hyperpigmented plaques
of thickened skin with accentuated furrows); scratching and rubbing lead to lichenification, most commonly in antecubital and popliteal
flexures; personal or family history of atopy.
Therapeutic considerations
· Food allergy: major role in atopic dermatitis; breast-feeding acts as prophylaxis against atopic dermatitis (and allergies in general);
breast-fed infants develop atopic dermatitis due to transfer of antigens in breast milk – mother should avoid common food allergens
(milk, eggs, peanuts, fish, soy, wheat, citrus, and chocolate); in older or formula-fed infants, milk eggs, and peanuts are the most
common foods inducing atopic dermatitis; virtually any food can be offending agent; diagnosis of food allergy – best via elimination
diet and challenge; lab methods to identify food allergens in eczema; ELISA IgE and IgG4. Food allergies linked to ‘leaky gut’, i.e.
increased gut permeability with increased antigen load on immune system and developing additional allergies; eliminating allergenic
foods can stop development of new allergies; avoiding offending foods for 1 year may eradicate allergy – loss rate after 1 year is
26% for five major allergens (egg, milk, wheat, soy, peanut) and 66% for other foods.
· Candida albicans: gastrointestinal (GI) overgrowth is the causative factor in allergies atopic dermatitis; elevated anti-Candida antibodies
are common in atopy; severity of lesions correlates with level of IgE antibodies to Candida; anti-Candida therapy may significantly
improve atopic dermatitis.
· Essential fatty acids (EFA) and prostaglandin
metabolism: AD patients have altered EFA and prostaglandin metabolism – increased linoleic acid levels to be increased with decreased
longer-chain PUFAs (gamma-linolenic acid and arachidonic acid) and omega-3 oils (eicosapentaenoic acid [EPA] and docosahexanoic acid
[
· Inhibiting excess histamine release: agents which stimulate cAMP production and/or inhibit cAMP phosphodiesterase reduce inflammatory
process in AD by reducing shunting to histamine; Coleus forskohlii strongly enhances cAMP; many botanicals inhibit diesterase – licorice
(Glycyrrhiza glabra) shows marked activity; flavonoids also inhibit cAMP phosphodiesterase – quercetin and hyperoside, the flavanes
orientin and vitexin, and the flavanone naringen; the common flavanol, rutin, has < 1/10 activity of quercetin; flavonoid extracts
from Vaccinium myrtillus, Rosa damascene, Ruta graveolans, Prunus spinosa and Crataegus pentagyna are the most potent inhibitors of
cAMP phosphodiesterase and also inhibit mast cell degranulation; flavonoid-rich extracts (grape seed, pine bark, green tea, Ginkgo
biloba) may prove helpful; Ginkgo terpenes (ginkgolides) antagonize platelet-activating factor (PAF), the key mediator in AD; PAF
plays central role in neutrophil activation, increasing vascular permeability, smooth muscle contraction (bronchoconstriction) and
reduced coronary blood flow; ginkgolides compete with PAF for binding sites; mixtures of ginkgolides and Ginkgo biloba extract (standardised
to 24% flavonglycosides and 6% terpenoids) demonstrate significant anti-allergy effects.
· Zinc: low zinc is common in AD; EFA metabolism is essential in AD (Zn required for delta-6-desaturase).
Botanical medicines
Two
categories below – internal and external.
· Licorice (Glycyrrhiza glabra): useful
in either application; internally, licorice has anti-inflammatory and anti-allergic effects.
· Chinese
herbal formula: used in double-blind crossover trials; contains licorice, plus Ledebouriealla seseloides, Potentilla chinensis, Clematis
chenisis, Clematis armandi, Rehmania glutinosa, Paeonia lactiflora, Lophatherum gracile, Dictamnus dasycarpus, Tribulus terrestris,
Schizonepeta tenuiflora – significant objective and subjective improvement in adults and children but many patients complained about
unpalatability of decoction; effect similar to topical hydrocortisone for eczema, contact and allergic dermatitis, and psoriasis.
Miscellaneous
factors
· Hypothyroid patients with eczema respond well to thyroid.
· Scratching: extremely detrimental to AD – breaks skin, aiding bacterial ingress, and promotes lichenification; factors which limit
itching promote healing and prevent recurrence.
· Emotional tension: aggravates
itching in AD; AD patients show higher anxiety, hostility, and neurosis than matched controls.
Therapeutic approach
Relieve
and prevent itching while treating underlying metabolic abnormalities; detect and control food and environmental allergies; normalise
prostaglandin metabolism; balance immune system.
· Conduct the ICIM Blood
Analysis followed by Naturopathic Consultation to help undercover underlying factors.
· Diet: 4-day rotation diet, eliminating all major allergens (milk, eggs, peanuts in 81% of cases); as patient improves, slowly reintroduce
allergens and reduce stringency of rotation diet; limit animal products; add fatty fish (salmon, mackerel, herring, halibut – so long
as patient has no known allergies to fish).
· Supplements:
- Vitamin A
- Vitamin E
- Zinc
- Quercetin
- EPA and
- Evening primrose oil
· Botanicals
- Arctium lappa or Taraxacum officinale
- Coleus forskohlii
- Glycyrrhiza glabra
· Topical treatment: glycyrrhetinic acid-containing commercial preparations; chamomile preparations; witch hazel preparations.
· Helpful tips: avoid sweating and rough-textured clothing; wash clothing with mild soaps only and rinse thoroughly; avoid exposure
to chemical irritants; local application of soothing lotions ameliorates itching (zinc oxide); but minimise greasy preparations that
block the sweat ducts.
· Psychological: determine if patient has significant
anxiety, hostility, or neurosis, refer to counsellor for therapy as needed.
This article is to be used for information and guide line purpose. Any advice and/or suggestions from this article should be supervised by your health professional. ICIM can offer a medical professional at the centre to guide you through your health complaints. Contact ICIM for more information.
All rights reserved to ICIM Medics Ltd.
ICIM Medics, St. Johns Grove, Johnstown, Naas, Co. Kildare, Ireland.
Tel: 00353 (0)45 844 819 - www.icim.ie - info@icim.ie
designed by: Felipe Reitz & Ciara Fitzpatrick